BK:NYSEThe Bank of New York Mellon Corporation analysis

The moving-average structure behind BIO-key International, Inc. is bearish at $2.98, with short-term averages lagging the long-term ones. RSI sits at 59.1, which reads as neutral, and MACD momentum is bullish. The recent range runs from support at $1.55 up to resistance at $4.66.
Multiples put this in undervalued territory: 13.6 times earnings against the sector's 27.4. Consensus targets land 570.0% above where the shares trade now. Revenue is growing at 13.1% on a -90.1% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 267.7%, a beta of -0.22 and a maximum drawdown of 84.0%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 91 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.